← Return to Keytruda + Lenvima For Recurrent Endometrial Serrous Carcinoma
DiscussionKeytruda + Lenvima For Recurrent Endometrial Serrous Carcinoma
Gynecologic Cancers | Last Active: May 10 9:30am | Replies (24)Comment receiving replies
Replies to "Re: aberrant over-expression of p53 (TP53): https://www.nature.com/articles/s41379-022-01102-x. Also, I'd like to report that I will likely..."
Thank you so much for the article! Very interesting. I'm happy to answer any other questions you have:)